Encouragingly, 88% of the 5046 people surveyed said they keep guinea pigs in groups of two or more, as is recommended by experts and, in fact, required by law in Switzerland. 88% also said they provide their guinea pig with additional space to roam outside of their housing.
Although only 3% of guinea pig owners said they insure their pet, 67% said they take their guinea pig to see the vet once a year or more.
When it comes to nutrition, 76% of owners say they believe feeding hay is the most important part of their guinea pig(s) diet and 65% say it is their guinea pigs’ primary food source. Burgess says that in an ideal world 100% of guinea pigs would be fed hay as their primary food source, so 65% shows there is room for improvement.
Peter Lancaster, marketing manager at Burgess Pet Care said: "Guinea pigs make fantastic pets but, as with other small animals, they have very particular needs when it comes to their welfare. Thankfully, according to the findings of our census, we found that the majority of guinea pig owners who provided answers on the five welfare needs – diet, company, health, environment and behaviour, are conscientious with their care, reflecting their dedication to keeping their pets happy.
"It was fantastic to see the number of guinea pig owners entering the census keep rising by the day, and we’re reassured that there are thousands of well-informed owners out there. However, despite these resoundingly positive findings, there is always work to be done when it comes to improving standards of animal welfare. The information we’ve received from this census does identify the gaps of knowledge in certain areas, and we anticipate these gaps to be much larger when it comes to less-informed and engaged guinea pig owners."
The Osurnia Ear Health Hub includes information about the treatment of canine otitis externa from dermatologists Sue Paterson and Natalie Barnard, advice about responsible antibiotic use, expert tips for vets to use in the consulting room and dog owner educational materials that veterinary staff can use in practice and online. It will also include a podcast interview with Sue.
The hub also provides information, videos and research about Osurnia.
Elanco Animal Health UK Marketing Manager, Rebecca Bryant said: "We know all too well the challenges vets face when treating canine OE and the significant impact the condition has on the quality of life of both the dog and the owner.
"The Osurnia Ear Health Hub is a new disease resource hub on MyElanco, which provides helpful resources for veterinary professionals looking for answers or to enhance their understanding of the disease. We hope that with more easily accessible information, this will help vets to treat OE cases and communicate with their clients."
Visit the canine ear health hub at: www.myelanco.co.uk
Whilst on the subject of information resources, this one has come to my attention. It's a list of other veterinary blogs and information resources: https://blog.feedspot.com/veterinary_blogs.
The Case Reports session has been devised by BSAVA’s programme committee to support RVNs who want to develop their presenting ability. It is specifically aimed at those with little or no experience of presenting and includes mentorship support for the selected candidates.
Claire Woolford RVN VTS (Anaesthesia), who sits on the BSAVA Congress Programme Committee said: "Case reports represent an engaging and interactive method for nurses to discuss unique cases or new techniques. What’s particularly special about the initiative at Congress 2020, is that we want to use the case report platform to support aspiring veterinary nurse speakers who could become speakers at Congress or other BSAVA events.
"We are particularly encouraging nurses with limited experience of presenting and offering the positive environment of Congress for them to develop their skills. All successful candidates will be assigned an experienced mentor who will aid them in preparing the final report to present at Congress."
A total of 8 winning applicants will be selected by the BSAVA Congress programme committee to present their case report. Each successful applicant will be given a 15-minute slot to present at Congress 2020, together with a complimentary Congress nurse pass for the whole of Congress for BSAVA VN members, or for Saturday 4 April for non-members. The presenter of the best case will also be awarded a BSAVA Manual of their choice.
For a chance to be involved, BSAVA is asking nurses to submit a brief synopsis of their case by 4th November 2019. The Case Report must focus on small animal cases, but any species and discipline can be discussed. Full submission information is available at www.bsavaevents.com
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
The session, which will be led by Catherine Oxtoby, will introduce VDS's VetSafe tool, designed both to help prevent a blame and shame culture, and to reduce clinical errors.
It will also provide an opportunity for delegates to share the challenges faced by RVNs with the VDS, and suggest how the organisation can develop and improve what it does for veterinary nurses.
The session will start at 12.00 noon for an early informal lunch (provided by VDS!) and discussion, finishing at 2pm.
To register for the event, visit: https://r1.dotmailer-surveys.com/a22wqh55-253ynf4e.
What3words divides the globe into a grid of 57 trillion squares measuring three metres by three metres and gives each one a unique, 3 word name.
The app uses the GPS on your mobile phone to display your approximate position on a map, which you can then zoom in on and pinpoint more precisely. It then gives you the 3 word address for the square you're in.
The reason the emergency services recommend What3words is that it can save them precious time getting to the scene of an accident. There are obvious benefits for veterinary surgeons too, not just when called to remote locations, but also when a client's postcode is ambiguous.
What3words is free of charge and can be downloaded for Android and Apple phones. There is also a What3words website, what3words.com, which provides the same service, but that only works online (whereas the app works offline too).
I've reviewed the app in more detail on YouTube here:
The BSAVA says there has been a real resurgence in the number of people keeping backyard poultry for a self-sufficient supply of food and because they often become part of the family, owners have come to expect a standard of veterinary care akin to that available for their cat or dog. Yet many veterinary surgeons are unfamiliar with consulting on and treating these birds.
The BSAVA Manual of Backyard Poultry Medicine and Surgery has been written by an international selection of specialist authors. It covers everything from husbandry and basic clinical techniques to medical and surgical treatment of conditions, and more advanced practices such as endoscopy and post-mortem examination.
The manual covers chickens, turkeys, ducks, geese, guinea fowl, ornamental pheasants and peafowl. The BSAVA says it is hoped that the manual will make treating backyard poultry more interesting and rewarding, and therefore encourage more practitioners to see feathered patients.
One of the editors, Guy Poland said: "We are very proud of the valuable contributions made by all the authors to the manual. We hope that their hard work will provide a useful resource for veterinary practitioners unfamiliar with poultry medicine to deliver improved care for their patients and maybe inspire an interest that they develop further."
BSAVA Manual of Backyard Poultry Medicine and Surgery is available in a printed edition (£85; £55 to BSAVA members) and online edition (£70.83+VAT; £45.83+VAT to BSAVA members).
Liz Leece, an RCVS and EBVS specialist in veterinary anaesthesia and analgesia (pictured right) and Massimo Mariscoli, an EBVS and RCVS specialist in veterinary neurology joined Paragon at the start of this month.
Liz is a past president of the Association of Veterinary Anaesthetists, is on the British Small Animal Veterinary Association’s congress organising committee and lectures to vets, nurses and occasionally human anaesthetists, all over the world.
She said: "I’m a keen supporter of the anaesthetist’s role in the referral hospital setting, safeguarding welfare and optimising the hospital experience for all our patients.
"One of my first tasks will be to establish a chronic pain management clinic at Paragon to aid any patients in need of such support.
"I also love teaching both inside and outside clinics and I’m currently involved in clinical research into brachycephalics, neuroanaesthesia and chronic pain."
Massimo grew up in Italy and graduated from the University of Bologna in 1990. He worked as head of small animal surgery and neurology at the Veterinary Teaching Hospital of the University of Teramo, before spells as lecturer and associate professor at the same centre.
The past president of the Italian Society of Veterinary Neurology (SINVet) moved to the UK in May 2017 to work as a neurology specialist and then head of neurology at a small animal hospital.
His main clinical interests are epilepsy, inflammatory disorders of the central nervous system and neurosurgery.
He said: "I was looking for a new challenge and was very pleased when I learned there was the possibility of setting up the neurology service at Paragon. I first visited the site in February and got a very good impression.
"Neurology has been split between internal medicine and surgery to date, so I will be looking to establish the service in its own right.
"Setting up a new service and new systems can be complex, so I will be taking my time and letting the service take shape naturally."
Paragon managing director Ian Monteith said: "Both Liz and Massimo are tremendous additions to our team and we’re delighted to be adding yet more high-calibre specialists to our ranks."
For more information, visit www.paragonreferrals.co.uk.
After the contamination was first identified, sales of the product in Australia were stopped immediately and Bova initiated an investigation.
The British Horseracing Authority then conducted its own analysis of samples of the UK product, discovering that it too was contaminated with testosterone.
However, Bova says the levels of testosterone in the end product were confirmed to be 400-700 pg/ml, which is less than one millionth of the internationally accepted standard for impurities (1 picogram being equal to one billionth of a milligram).
Nick Bova, managing Director of Bova UK, said: "We have consulted veterinary pharmacologists and sports medicine specialists who have given their opinion that these levels are within accepted standards and could neither have a clinical effect nor result in a positive blood or urine test for testosterone in competition horses.
"The levels of testosterone within the product are inconsequential compared to endogenous production in mares and geldings as well as stallions and higher levels are found frequently in feed and water sources; testosterone being a common compound produced by humans and animals from multiple organs."
The source of the contamination was traced to the excipient used in the product, which was used by Bova Aus and Bova UK. Both companies have now switched their supplier of this excipient. Bova says all testing done on the new supplier has shown no traces of testosterone, even with the new extra sensitive method of analysis which is capable of reaching picogram levels.
Nick added: "Whilst we hope to reassure you that the use of long acting injectable omeprazole will not have had adverse implications for your patients or clients we can also reassure you that we are not complacent about the presence of impurities in any of our products, particularly an impurity that is of such significance to equestrian sport.
"Although the level of impurities is well within the accepted international standard, we have changed the supplier of the excipient in question. We have established an analytical method capable of testing down to picogram levels, which has been used to test the end product to ensure there are no further concerns with future batches.
"We sincerely apologise for any inconvenience this issue may have caused. Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment and we can reassure anyone who has used the product in recent months, or has product that they are due to use, that they can do so safely.
"However, we would draw attention to the recent statement from the BHA that they do not wish the product to be used in horses in training currently."
Visit www.bova.co.uk for further information.
Ophtocycline is licensed for the treatment of keratitis, conjunctivitis and blepharitis caused by Staphylococcus spp., Streptococcus spp., Proteus spp., and/or Pseudomonas spp.
Dechra says chlortetracycline hydrochloride works against both aerobic and anaerobic Gram-negative and Gram-positive bacteria.
The recommended dosage is four times a day for five days. The 10 mg/g ophthalmic ointment has a 14-day broached shelf life. There is a one-day withdrawal period for meat and offal.
Dechra Brand Manager Carol Morgan said: "Ophtocycline provides veterinary professionals with a targeted treatment to effectively tackle the growing and reproducing bacteria that causes these eye conditions.
"Chlortetracycline is a bacteriostatic antibiotic which interferes with bacterial protein synthesis in the rapidly growing and reproducing bacterial cell and has both time-dependent and concentration dependent effects.
"We are very pleased to be able to roll out this product to the UK market as part of our ophthalmic range alongside popular products such as Isathal."
For more information visit: www.dechra.co.uk
Earlier this year, the RCVS Council approved the roll-out of a more outcomes-based model of CPD to encourage veterinary professionals to engage in greater reflection on learning and development, and the impact that it has on their professional practice.
To support this approach, Council also approved the development of a new CPD recording platform designed to be more intuitive and to make it easy to record CPD in real time.
The College says the new platform – which has the working title of 'One CPD' – will be a ‘one stop shop’ CPD management solution for veterinary surgeons and nurses at all stages of their careers, including veterinary students and student veterinary nurses.
Richard Burley, RCVS Chief Technology Officer, said: "We’re excited to open up access to this powerful, next-generation, tool we’ve been building and welcome our members into an important phase of the development process. Testing with our members will be absolutely critical in delivering the very best experience possible for all those that use 'One CPD' in the future. Ease of use and truly valuable functionality are key deliverables for us and both these need the feedback of our members to perfect."
Dr Linda Prescott-Clements, RCVS Director of Education (pictured right), added: "The first stage of the development of the CPD recording platform is due to finish in October and so we are looking for a cohort of both veterinary surgeons and nurses who can spend a few months this autumn using the new platform to record and reflect on their CPD, in order to test out some of the new features which aim to make this process so much easier to do. We will consider their feedback carefully in order to improve the recording platform ready for launch in January 2020.
"The new ‘One CPD’ platform will ultimately replace the current Professional Development Record, and its use will become mandatory for recording CPD from January 2022.
"In addition to setting up the testing group, we are also looking to meet with key CPD providers for veterinary surgeons and veterinary nurses over the coming months to discuss our plans for outcomes-based CPD and the development of the recording platform in greater detail."
Veterinary nurses who'd like to take part in the testing for the CPD app, as well as CPD providers who want to discuss the College’s CPD policy plans, should contact Jenny Soreskog-Turp, RCVS CPD Officer, on cpd@rcvs.org.uk or 020 7202 0701.
The committee heard five charges against Dr Davies at a resumed hearing of an inquiry which was originally adjourned in January and then July 2018. The decision was made, at both the 2018 hearings, to postpone the final decision on the sanction.
The first two charges against Dr Davies related to convictions for drink driving in March 2014 and October 2015 for which she received driving bans of 17 and 45 months.
The third charge related to her breaching a number of undertakings she had entered into as part of the College’s Health Protocol, including her consuming alcohol on four occasions between May 2015 and January 2016 and missing a pre-arranged appointment with a consultant psychiatrist appointed.
The fourth and fifth charges related to being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016 which was also in breach of her undertakings under the Health Protocol.
At Dr Davies' first Disciplinary Committee hearing in January 2018, she admitted all five charges against her and also accepted that her conduct was disgraceful conduct in a professional respect.
The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
At the conclusion of its hearing on 23 January 2018 the Committee decided to postpone its decision regarding sanction for six months on the basis of Dr Davies’ entering into undertakings, including not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement and to undergo blood and hair tests for alcohol consumption every two months.
At the resumed hearing on 30 July 2018, Dr Davies’ Counsel submitted on her behalf that she wished to return to practise and the Committee reviewed evidence that she provided to demonstrate she had complied with her undertakings.
However, the Committee retained concerns about Dr Davies' return to practise and therefore required her to identify a veterinary surgeon who would agree to act as her mentor, noting that the mentor would have to be acceptable to the College as someone suitable to act in that capacity.
The Committee also required the continuation of the requirements for abstinence from alcohol and the programme of blood and hair testing.
A further requirement of the Committee was that Dr Davies should make a disclosure to any new employer of her appearances before the Committee in January 2018 and in July 2018 and of the decisions it made.
The final requirement of the Committee was that the respondent should not accept a ‘sole charge position’ at any time during her employment during this next period of postponement of sanction. The Committee then directed that the hearing be postponed for a further 12 months.
The Disciplinary Committee resumed its inquiry on 7th August 2019, when Dr Davies submitted documentary proof and medical records to demonstrate she had complied with all her undertakings given at the last hearing. The Committee also heard from Dr Davies’ appointed veterinary mentor who provided a statement that concluded that she no longer needed monitoring or supervision.
The Committee then considered what sanction to impose on Dr Davies.
Ian Green, chairing the Committee and speaking on its behalf, said: "The view of the Committee is that the respondent has to date overcome her addiction to alcohol and, given that her competence as a practising veterinary surgeon is not disputed, that she should therefore be permitted to return to her chosen profession. However, in the judgment of this Committee the seriousness of the offences to which the Respondent has pleaded guilty means that a sanction of “No Further Action” cannot be justified."
The Committee therefore decided that the most proportionate sanction was for Dr Davies to be reprimanded as to the conduct she admitted at previous hearings and that she be warned as to her future conduct.
Ian added: "The respondent must understand that she has been given an opportunity to prove that, for the remainder of her time in practice, she can meet the high standards expected of all registered veterinary surgeons from both other practitioners and from members of the public who entrust the care and treatment of their animals to members of this profession."
The awards, comprising academic book vouchers, were presented at the University’s RCVS ceremony after graduation earlier this month.
Dana Flint, BSc Veterinary Nursing and Bioveterinary Science, won the award for the most engaged veterinary nursing student on EMS placement. Dana showed great engagement with the EMS process of finding and booking suitable placements. She had good communication skills with the EMS office throughout.
Meanwhile, The Rowe Veterinary Hospital in Bristol won the students’ award for most supportive veterinary nursing placement practice 2019. Comments received from students included: ‘They helped me not only complete my nursing progress log but finish it early’. ‘The whole team were so supportive and they were happy to help with anything’. ‘They boosted my confidence so much….and made me feel like one of the team’.
Sarah Heming, Director of Public Affairs and Customer Relations at Zoetis said: "Zoetis has a high focus on supporting the professional advancement of the veterinary profession. We are proud sponsors of the EMS Recognition Awards for Bristol University alongside other initiatives such as the Young Vet of the Year Awards in partnership with the British Veterinary Association.
"The initial stages of a veterinary career are pivotal so helping winning individuals to invest in academic or professional resources to support their continued development in practice can be very beneficial. We would also like to formally thank the winning practices for their invaluable commitment and support."
Katie (pictured right) was awarded £1,000 for her research into the use of an ATP bioluminescence meter to monitor cleaning, with the aim of improving hospital hygiene.
The research is part of her study towards her Certificate in Surgical Nursing.
Katie said: "While we don’t have a clinical infection problem at our hospital I believe that there is always a need to improve hygiene standards across the industry as a whole. My aim is to prove that there are easily implementable, and affordable, processes that will improve the hygiene levels of the clinical areas in which I will work. I hope that this can then be rolled out further across the hospital and implemented across our branches and the veterinary industry as a whole."
Michelle Townley, veterinary advisor at MSD Animal Health said: "As the first veterinary nurse to receive one of our research bursaries it’s appropriate that this has been awarded for work that can easily support future developments within the industry. We are committed to preserving and improving the health, well-being and performance of animals so this piece of research fits well with this important goal.
MSD Animal Health launched its first Veterinary Nurse Research Bursary last year, adding to its existing vet surgeon and vet student schemes. One £1000 bursary has been made available to the student or qualified veterinary nurse in the UK with the best research project application. It offers an opportunity to win additional prizes of £1,000 and £500 for the best research projects and presentations at the MSD Animal Health’s Research Bursary Day in June 2020.
For further details go to the MSD Animal Health Research Bursary website at www.msdahresearchbursary.co.uk.
People are invited to organise or join a walk to raise money for Canine Arthritis Management and its work to educate both dog owners and veterinary professionals about how even the smallest of changes can help to enhance the life of a dog with arthritis.
CAM highlights recent work from the Royal Veterinary College and University of Sydney through VetCompass, which highlighted some of the biggest welfare challenges facing our pet population including obesity, dental disease and osteoarthritis, with osteoarthritis identified as one of the most severe conditions.
Hannah said: "We need to start more conversations about arthritis; both dog owners and vets need to be more aware of the steps we can take to help prevent arthritis, and where dogs are affected, how we can take positive action to help them live fulfilled and comfortable lives."
Hannah says that arthritis is currently one of the biggest causes of owners choosing to euthanise their dogs, and she hopes that owners taking part in the walks will help spread the word that arthritis can be managed.
To find out more about the Big September Walks visit www.facebook.com/CAMBigSeptemberWalks
As a result of the new partnership, customers of Bought By Many will have access to free video consultations with UK-registered veterinary surgeons via the FirstVet app.
In their blurb, the companies say that: "Many common pet health issues can be treated in the comfort of their own home, meaning owners only need to take their pet to the vet when absolutely necessary. Bought By Many customers can save time, money and potential stress to their pet by using the free FirstVet service. When a referral to a local vet is needed, FirstVet provides detailed notes of the initial consultation to both the owner and the vet."
David Prien, FirstVet’s CEO & co-founder, said: "FirstVet couldn't be more excited to offer our veterinary video consultation service together with Bought By Many in the UK.
"From our first meeting with the Bought By Many team, we knew that our values were aligned. We both share a mission to bring the best that technology has to offer both to pet owners and to the veterinary care process.
"Offering pet owners the chance to speak face-to-face with an experienced veterinarian via a video call is a great way to make sure that all pets are getting the right treatment, as fast as possible, in the right location."
For more information on Bought by Many, visit boughtbymany.com/pet-insurance.
The poster grades faeces from one (kickable) to six (most certainly not kickable).
James Kyffin, Veterinary Director at Protexin Veterinary said: "We believe that Poop Points offers pet owners a fun and engaging way to monitor their pet’s faeces."
That, surely, must win James the "Oxymoronic Veterinary Quote of the Year Award 2019".
More seriously, he went on to say: "It is important to raise awareness of alterations in animal’s faecal scores and ensure that this is communicated to their veterinary surgeon in an effective way."
Practices in the UK and Ireland can order their free poster on Protexin's website: https://www.protexinvet.com/pooppoints, or by emailing info@protexin.com.
Protexin will also be promoting digestive health advice on its website and social channels (@Protexin Veterinary on Facebook and Instagram), which practices can share and use.
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
The charity says that although histiocytic sarcoma is rare, it is an aggressive form of cancer which Flatcoated Retrievers are particularly susceptible to.
According to the AHT, almost half of all affected Flat-coated Retrievers will have a tumour in multiple locations in the body at the time of diagnosis. The outlook for these dogs is very poor and, in most cases, means they receive a terminal diagnosis.
The new research revolves around microRNAs, abnormal levels of which are often found in tumours. In addition, different microRNAs are involved in different cancers. These cancer-specific microRNA signatures can be found within the blood of cancer patients, meaning that a tumour could potentially be diagnosed with a blood test.
To start with, the researchers say they plan to confirm if there is a specific microRNA signature that is unique to histiocytic sarcomas amongst tumours and normal tissue samples from Flatcoated Retrievers. If a signature is identified, the project will investigate if measuring the levels of these microRNAs within a Flatcoated Retriever tissue sample can be used to accurately identify a histiocytic sarcoma. If it can, additional funding will be sought for more research to identify if the microRNA signature is also detectable in the blood of affected dogs, and thence to develop a blood test.
If it comes off, this would mean that a blood sample from a Flatcoated Retriever that was lame, or was showing non-specific clinical signs of the disease such as depression, lethargy, appetite or weight loss, could be tested for the presence of the histiocytic sarcoma-associated microRNAs.
A dog with a positive test result could then have an early MRI scan and histopathology done to confirm the diagnosis, hopefully at a stage where treatment would be more successful.
Dr Anna Hollis, cancer researcher at the Animal Health Trust, said: "I have Flatcoated Retrievers and have lost one of them to histiocytic sarcoma - it is absolutely devastating. This research could make a significant difference, and that is a huge personal motivation for me. Histiocytic sarcoma is a particularly tricky cancer to diagnose, because the tumours are frequently located deep within or between the muscles of the upper limbs - underneath the shoulder is a common location.
"Often lame dogs are rested and given pain relief before imaging is sought. Delayed diagnosis is a potential problem with histiocytic sarcoma given its aggressive nature and ability to spread rapidly to other locations within the body. If we could identify affected dogs at an earlier stage, this may allow more successful treatment of the disease."
The research project has been funded by the Flatcoated Retriever Society (FCRS) and the FCRS Rescue, Rehousing and Welfare Scheme. The Flatcoated Retriever Breed Health Co-ordinator, Liz Branscombe, said "Sadly, there is a high incidence of this aggressive form of cancer in our beautiful breed. Early detection of the disease is key in optimising cancer treatment and prolonging survival time so the prospect of a diagnostic blood test for use in the future is exciting.'
Photo: Liz Branscombe, Dr Mike Starkey and Dr Anna Hollis of AHT and Brian Jones of FCRS Rescue, Rehousing and Welfare.
Vetemex has a 56-day broached shelf life and uses benzyl alcohol as the excipient, rather than metacresol.
Virbac points to a study in which benzyl alcohol achieved a 78% reduction in pain score immediately post-injection, and a 53% reduction in pain score in the 2-minute period post-injection, compared to Metacresol1.
Vetemex is presented in a 20ml bottle and is available from the veterinary wholesalers now.
Claire Lewis, Product Manager at Virbac said: "Vetemex is a valuable addition to the already extensive Virbac portfolio. We are pleased to be able to offer vets this new, and more comfortable to administer, antiemetic option."
For more information on Vetemex, speak to your Virbac Territory Manager.
Reference
The Disciplinary Committee had found Dr Schulze Allen guilty of four charges, namely that he had been convicted of the criminal offence of petty theft in the US which rendered him unfit to practise, and that on three subsequent occasions, twice to the RCVS and once to a notary in California, dishonestly represented that he had no criminal convictions.
Following the DC hearing, Dr Schulze Allen submitted an appeal to the Privy Council. The basis of his appeal revolved around whether, under Californian law, his conviction for petty theft was a conviction for a criminal offence or an infraction, and whether an infraction under US law was a criminal offence.
The RCVS had argued that while the theft is not a criminal felony in California, it would be considered so under English law.
However, the Board of the Privy Council which heard the appeal – comprising Lords Wilson, Carnwath and Lloyd-Jones, found the College had not proven beyond all reasonable doubt that Dr Schulze Allen was convicted of a criminal offence under Californian law. It therefore upheld his appeal against the DC’s finding that he had committed a criminal offence.
The Privy Council then considered Dr Schulze Allen’s appeal against the third and fourth of the charges against him - that he was dishonest in his representations to the College that he did not have a ‘criminal’ conviction and did not have a ‘criminal record’. The Privy Council found that, since the conviction for petty theft was an infraction, and was not a criminal offence and did not leave Dr Schulze Allen with a criminal record, then, strictly speaking, his representations to the RCVS were not false and so upheld his appeal against these two charges.
The Privy Council then considered Dr Schulze Allen’s appeal against the College’s second charge against him. This charge was that he had, in a written application for restoration to the Register, represented that he did not have any cautions, criminal convictions or "adverse findings". The College argued that he still had a responsibility to make a full and frank disclosure about his infraction, even if it did not meet the threshold of ‘criminal’ under Californian law.
The Board of the Privy Council said it had, on Dr Schulze Allen’s behalf, done its best to identify some argument that his conviction for a petty theft infraction did not amount to an "adverse finding", but failed. Rather, it found that "the conviction obviously amounted to an adverse finding."
The Board added that "there is no material by reference to which the Board [of the Privy Council] can depart from the [Disciplinary] Committee’s conclusion that, in answering “no” to that question, he knew that his answer was untrue. In other words, his denial was dishonest."
The Board therefore allowed the appeal against the DC’s conclusion on the first, third and fourth charges. But it dismissed the appeal against its conclusion on the second charge, namely that in that regard Dr Schulze Allen had been guilty of disgraceful conduct in a professional respect."
The Board then set aside the original sanction, that Dr Schulze Allen be removed from the Register, and tasked the Committee with identifying the appropriate sanction in relation to the second charge.
The Disciplinary Committee will now hold a further hearing to decide the sanction, at some time in the future. In the meantime Dr Schulze Allen remains on the Register of Veterinary Surgeons.
Amy Scott MRCVS, Boehringer Ingehlheim’s performance horse portfolio manager, said: "Arti-Cell Forte is the first 'ready-to-use' stem cell-based product to be licensed in any veterinary species, and the only stem cell treatment to contain induced cells, representing a significant leap forward in both stem cell therapies and medicine as a whole.
"Arti-Cell Forte contains stem cells that have been chondrogenically induced and therefore primed to develop into the cartilage cell lineage. Studies have shown that chondrogenically induced stem cells demonstrate an enhanced clinical outcome compared to un-induced stem cells in the treatment of joint disease in horses¹."
"This makes Arti-Cell Forte a highly targeted and effective treatment for cartilage damage associated with degenerative joint disease."
Arti-Cell Forte is available direct from Boehringer Ingelheim to veterinary practitioners.
It needs to be stored at ultra-low temperatures to maintain its two year shelf life from manufacture, either frozen at -70 ⁰C to -90 ⁰C (dry ice, -80 ⁰C freezer) or -196 ⁰C (liquid nitrogen) until immediately prior to injecting.
The company is providing full training on storage and administration via face-to-face CPD at practice meetings or specific CPD events*.
For more information, contact your local territory manager or ring Boehringer's Technical Services Team on 01344 746957, or email vetenquiries@boehringer-ingelheim.com
The company points to a study which showed that cats treated Bravecto Plus showed no visible signs of mites at 14 days and 100% efficacy was confirmed at 28 days1. This, says the company, means that Bravecto Plus now gives 12 week control of fleas and ticks, eight week prevention of heartworm disease, treatment of roundworm and hookworm, and treatment of ear mites.
Hannah Newbury, Companion Animal Technical Lead at MSD Animal Health said: "With 1 in 4 cats in the Big Flea Project study having fleas2, we can conclude that pet owner compliance to parasite prevention is currently poor.
"This new licence is an important development for vets and cat owners, offering greater convenience, while helping improve flea and tick compliance. Bravecto Plus builds on the qualities of Bravecto and offers vets and cat owners another tool in the fight against an even broader range of potentially harmful parasites.
"Research by MSD Animal Health shows that 82% of cat owners believe that the ideal flea and tick treatment lasts longer than 2 months3 and vets can offer their cat owners this and more with BRAVECTO PLUS due to its 12 week duration of activity4.
For further information contact your MSD Animal Health Account Manager.
References
The Disciplinary Committee heard three charges against Dr Dhami, relating to events which took place while he was in practice at Vets4Pets in Market Harborough, Leicestershire.
The first charge against him was that, in November 2017, he used excessive force in kicking and stamping on a Staffordshire Bull Terrier he was treating.
The second charge was that, between in October and November 2017, he failed to pay adequate regard to the welfare of a Jack Russell in his care by leaving it in a sink without adequate reason and for an excessive period of time.
The third charge was that, between April and March 2018, he failed to have adequate regard to the welfare of a six-to-eight week old kitten, including providing bedding and warmth.
At the outset of the hearing Dr Dhami admitted to lightly kicking the dog, but denied forcefully kicking it and also denied that he had stamped on the dog, as well as denying the other two charges against him.
In considering the circumstances of the first charge, the Committee heard evidence from two of Dr Dhami’s colleagues stating that the dog had bitten him whilst he was cleaning its ears and, following this, he took the dog out of the consulting room, closed the door and whilst holding the dog’s lead then proceeded to kick her twice, knocking her along the floor both times, and then finally stamp on her when she was prone.
Dr Dhami disputed his colleagues' version of events and stated that he had only delivered two light kicks to the dog’s rump, that neither of these had made her fall to the floor and also denied in categorical terms that he stamped on the animal. Furthermore, he also denied the second and third charges against him.
In considering the evidence as to whether Dr Dhami kicked and stamped on the dog, the Disciplinary Committee found the evidence of his two colleagues to be credible and reliable, and so found all aspects of the charge proven.
Ian Green, chairing the Committee and speaking on its behalf, said: "For the avoidance of doubt, the Committee finds that the admitted kicks administered to [the animal] by the respondent were of significant force. The Committee rejects the respondent’s assertion that the admitted kicks amounted to mere taps on the backside. The Committee finds that the ‘stamping’ was also of significant force."
In regards to the second and third charges, the Committee was not satisfied that the charges had been proven by the evidence it heard and therefore dismissed them both.
Having found all parts of the first charge proven, the Committee then went on to consider whether or not Dr Dhami’s conduct amounted to serious professional misconduct, something that Dr Dhami, following the Committee’s decision on the facts, through his counsel, had admitted.
The Committee identified a number of aggravating factors, including the real risk of physical harm to the animal and the deliberate nature Dr Dhami’s conduct against the animal, committed in anger.
In mitigation, the Committee accepted that this was an isolated incident and that Dr Dhami had been bitten and was in pain. The Committee therefore found that Dr Dhami’s admission of serious professional misconduct was ‘properly and prudently made’.
The Committee then considered what sanction to impose on Dr Dhami. In doing so it took into account some of the written testimonials and character witnesses called on behalf of Dr Dhami. The Committee was also satisfied that Dr Dhami had had a hitherto long and unblemished career, that he had apologised to colleagues immediately after the incident and that, since the events, he had continued to work as a veterinary surgeon without any problems.
In relation to insight about the event, the Committee accepted Dr Dhami had provided some evidence of reflection, in that he admitted kicking the dog and accepted that this conduct, once found proven, amounted to serious professional misconduct.
The Committee decided that suspending Dr Dhami from the Register for four months would be the most proportionate sanction.
Ian Green concluded: "Having regard to all the matters urged by way of mitigation, and having taken into account all the evidence that it has heard, the Committee is satisfied that a period of suspension is sufficient in this case to protect the welfare of animals, maintain public confidence and to declare and uphold proper standards of conduct."
Dr Dhami has 28 days from being informed of the outcome of the hearing in which to make an appeal to the Privy Council.
Open to anyone working in a veterinary setting at any stage of their career, the competition rewards teams and individuals (clinical and non-clinical), who have achieved better outcomes through QI initiatives for patients, clients, the business or the working environment.
Individual winners will be crowned 'Knowledge Champions' and one team will become RCVS Knowledge’s 'Champion Practice'.
Each winner will also receive a £250 reward, tickets to the awards ceremony next calendar year and the opportunity to work with RCVS Knowledge to further promote their quality improvement work.
Candidates can nominate themselves or others for an award.
If you want to nominate a colleague, the deadline is 17thOctober. The deadline to apply on your own behalf or that of your team/practice is 29th November 2019.
Full details are available online: bit.ly/KnowledgeAwards.
Executive Director of RCVS Knowledge, Chris Gush said: "The 2019 awards shed light on the very good work those in the profession are doing to continually enhance quality, so we are delighted to bring the competition back for 2020.
"It is a great opportunity for individuals and teams to showcase their quality improvement initiatives. Whether it is clinically focused or aiming to improve procurement, we are keen to hear about the work that is underway."
Last year's awards highlighted inspirational QI projects such as a drugs audit that led to a ten-fold improvement in usage discrepancy; a quarterly clinical audit that enhanced nursing expertise and trust from veterinary surgeons; and the introduction of guidelines that coincided with the subsequent treatment of 2,639 additional animals.
The case examples submitted by each winner are available to download for free:
'Champion Practice' Vets Now Macclesfield for its anaesthesia audit.
'Knowledge Champion' Louise Northway RVN, Wendover Heights Veterinary Centre, for her anaesthesia audit.
'Knowledge Champion' Alison Thomas MRCVS, Blue Cross, for her case study: Creating clinical guidelines.
'Knowledge Champion' Angela Rayner MRCVS, CVS Group plc, for her case study: Controlled drugs process audit.
For more case examples and QI resources, visit: bit.ly/QIKnowledge